Completed NA INTERVENTIONAL 4-arm NCT05960786

Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand

Sponsor: MCRA

Conditions BPPV Benign Paroxysmal Positional Vertigo Labrynthitis Meniere Disease Migraine Associated Vertigo Ménière's Vertigo Uncompensated Unilateral Vestibulopathy Vertigo Vestibular Disorder Vestibular Migraine

Interventions Otoband Experimental Otoband Sham

Updated 6 times since 2023 Last updated: Mar 17, 2025 Started: Feb 2, 2023 Primary completion: Dec 7, 2023 Completion: Dec 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05960786, this NA trial focuses on BPPV and Benign Paroxysmal Positional Vertigo and remains completed. Sponsored by MCRA, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Apr 2025 — Sep 2025 [monthly]

Completed NA
Sep 2024 — Apr 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Aug 2023 — Mar 2024 [monthly]

Recruiting NA

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MCRA
Otolith Labs

Data source: Otolith Labs

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Washington D.C., United States